We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Gilead subsidiary Asegua Therapeutics won the exclusive contract to treat Louisiana’s poor and imprisoned hepatitis C patients, health officials in the Pelican State announced Tuesday. Read More
Purdue and its owners on Tuesday agreed to pay $270 million to settle a lawsuit bought by Oklahoma officials, avoiding what would have been the first jury trial in a nationwide opioid crisis that may end up costing drugmakers billions. Read More
Johnson & Johnson and Bayer will pay $775 million to settle nearly 25,000 lawsuits alleging that the companies didn’t properly warn the public that their blockbusting blood thinner Xeralto (rivaroxaban) might cause bleeding. Read More
Eli Lilly, under pressure from many quarters over the price of its medicines, released a report over the weekend saying the net price of its insulin has fallen more than eight percent over the past five years. Read More
Drugmakers should use industry-driven voluntary standards but regulators will give priority to standards that are internationally harmonized, the FDA said in a final guidance issued Monday. Read More